Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1
Kyle G. Rodino, David R. Peaper, Brendan J. Kelly, View ORCID ProfileFrederic Bushman, Andrew Marques, Hriju Adhikari, Zheng Jin Tu, Rebecca Marrero Rolon, Lars F. Westblade, Daniel A. Green, Gregory J. Berry, Fann Wu, Medini K. Annavajhala, Anne-Catrin Uhlemann, Bijal A. Parikh, Tracy McMillen, Krupa Jani, N. Esther Babady, Anne M. Hahn, Robert T. Koch, Nathan D. Grubaugh, Yale SARS-CoV-2 Genomic Surveillance Initiative, Daniel D. Rhoads
doi: https://doi.org/10.1101/2022.04.25.22274187
Kyle G. Rodino
1Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
David R. Peaper
2Department of Laboratory Medicine, Yale University, New Haven, Connecticut
Brendan J. Kelly
3Division of Infectious Diseases, Department of Medicine and Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Frederic Bushman
4Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Andrew Marques
4Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Hriju Adhikari
4Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Zheng Jin Tu
5Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
Rebecca Marrero Rolon
6Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York
Lars F. Westblade
6Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York
7Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York
Daniel A. Green
8Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York
Gregory J. Berry
8Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York
Fann Wu
8Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York
Medini K. Annavajhala
9Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York
Anne-Catrin Uhlemann
9Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York
Bijal A. Parikh
10Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
Tracy McMillen
11Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Krupa Jani
11Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
N. Esther Babady
11Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
12Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Anne M. Hahn
13Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut
Robert T. Koch
13Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut
Nathan D. Grubaugh
13Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut
14Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut
Daniel D. Rhoads
5Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
15Department of Pathology, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio
16Infection Biology Program, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio
Posted April 28, 2022.
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1
Kyle G. Rodino, David R. Peaper, Brendan J. Kelly, Frederic Bushman, Andrew Marques, Hriju Adhikari, Zheng Jin Tu, Rebecca Marrero Rolon, Lars F. Westblade, Daniel A. Green, Gregory J. Berry, Fann Wu, Medini K. Annavajhala, Anne-Catrin Uhlemann, Bijal A. Parikh, Tracy McMillen, Krupa Jani, N. Esther Babady, Anne M. Hahn, Robert T. Koch, Nathan D. Grubaugh, Yale SARS-CoV-2 Genomic Surveillance Initiative, Daniel D. Rhoads
medRxiv 2022.04.25.22274187; doi: https://doi.org/10.1101/2022.04.25.22274187
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1
Kyle G. Rodino, David R. Peaper, Brendan J. Kelly, Frederic Bushman, Andrew Marques, Hriju Adhikari, Zheng Jin Tu, Rebecca Marrero Rolon, Lars F. Westblade, Daniel A. Green, Gregory J. Berry, Fann Wu, Medini K. Annavajhala, Anne-Catrin Uhlemann, Bijal A. Parikh, Tracy McMillen, Krupa Jani, N. Esther Babady, Anne M. Hahn, Robert T. Koch, Nathan D. Grubaugh, Yale SARS-CoV-2 Genomic Surveillance Initiative, Daniel D. Rhoads
medRxiv 2022.04.25.22274187; doi: https://doi.org/10.1101/2022.04.25.22274187
Subject Area
Subject Areas
- Addiction Medicine (352)
- Allergy and Immunology (675)
- Anesthesia (181)
- Cardiovascular Medicine (2672)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12290)
- Forensic Medicine (10)
- Gastroenterology (767)
- Genetic and Genomic Medicine (4140)
- Geriatric Medicine (388)
- Health Economics (682)
- Health Informatics (2683)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3923)
- Nursing (212)
- Nutrition (583)
- Oncology (2060)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1125)
- Primary Care Research (459)
- Public and Global Health (6560)
- Radiology and Imaging (1412)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (188)
- Urology (169)